key: cord-1032892-x95g5mq9
authors: Tsuzuki, Shinya; Asai, Yusuke; Matsunaga, Nobuaki; Ishioka, Haruhiko; Akiyama, Takayuki; Ohmagari, Norio
title: Impact of regional heterogeneity on the severity of COVID-19
date: 2022-01-05
journal: J Infect Chemother
DOI: 10.1016/j.jiac.2021.12.032
sha: 0de26b0925ad367415759c2657d8419524e59d84
doc_id: 1032892
cord_uid: x95g5mq9

The main objective of the study is to assess the impact of regional heterogeneity on the severity of COVID-19 in Japan. We included 27,865 cases registered between January 2020 and February 2021 in the COVID-19 Registry of Japan, to examine the relationship between the National Early Warning Score (NEWS) of COVID-19 patients on the day of admission and the prefecture where the patients live. A hierarchical Bayesian model was used to examine the random effect of each prefecture in addition to the patients’ backgrounds. Additionally, we compared the results of two models; one model included the number of beds secured for COVID-19 patients in each prefecture as one of the fixed effects, and the other model did not. The results indicated that the prefecture had a substantial impact on the severity of COVID-19 on admission, even when considering the effect of the number of beds separately. Our analysis revealed a possible association between regional heterogeneity and increased/decreased risk of severe COVID-19 infection on admission. This heterogeneity was derived not only from the number of beds secured in each prefecture but also from other factors.

Coronavirus disease 2019 (COVID-19), which is caused by the SARS-CoV-2 virus, has become a global health threat, imposing a substantial disease burden on our society [1] .

Although it has fluctuated, the epidemic has continued [2] .

COVID-19 is more infectious than other respiratory tract infections [3] , such as influenza, and is sometimes fatal to the elderly and those with underlying medical conditions. Considering these characteristics, the capacity of healthcare facilities for COVID-19 patients is an important factor in the management of newly infected COVID-19 patients.

When we consider countermeasures against COVID-19, the proportion of patients with severe disease is extremely important [4] . Mild and/or asymptomatic cases can be easily managed as they need no specific treatment. Conversely, severe cases often require intensive, multidisciplinary care. Furthermore, the duration of the disease in severe cases is generally longer than that of other viral pneumonias [5] and therefore places a greater burden on healthcare capacity. It is important, therefore, to precisely recognize the factors associated with the severity of COVID-19. For example, new variants may contribute to the severity of COVID-19 cases [6] . However, such variants are not the only determinants of severity; age, sex, past medical history, and many other factors have been attributed to the severity of COVID-19 [4, 7] . In addition, it is conceivable that there are other factors J o u r n a l P r e -p r o o f influencing the severity of COVID-19 aside from such biological aspects.

In Japan, the number and proportion of severe COVID-19 cases vary by prefecture.

This phenomenon seems difficult to explain; nevertheless, there are differences in the management of COVID-19 cases among prefectures, and these differences may contribute to the capacity of healthcare facilities in each prefecture. Understanding the extent of such regional differences, in other words, "regional heterogeneity" which includes multiple factors such as differences in the management of COVID-19 cases, diagnosis processes, capacity of healthcare facilities, and so forth. We had used the term to mean the various factors that affect the severity of COVID-19 cases at the time of admission, will help us tailor the countermeasures against COVID-19 more appropriately in each prefecture. The main objective of our study was to examine this regional heterogeneity quantitatively.

We included 27,865 cases registered between January 2020 and February 2021 in the COVID-19 Registry of Japan (COVIREGI-JP) [8] . We used a Bayesian hierarchical model to construct a prefecture-specific random intercept to evaluate the effect of regional heterogeneity.

The capacity of medical facilities can be evaluated by the number of hospital beds; however, the differences in health policies against COVID-19 among local municipalities should also be taken into consideration as the planning of hospital bed distribution and the priority of hospitalization indication are influenced by the policy of each local municipality. Considering this, we constructed two models: one which included the number of beds secured for COVID-19 patients in each prefecture as a fixed effect (model B) and one which did not (model A).

The independent variable was the National Early Warning Score (NEWS) [9], which is a tool developed by the Royal College of Physicians to improve the detection of and response to clinical deterioration in adult patients and showed a good performance in the assessment of COVID-19 patients' severity [10] , on the day of admission, and the explanatory variables for the fixed effect were sex, age of 65 years and older, and any risk factor of severe infection (cardiovascular disease, cerebrovascular disease, chronic respiratory disease, liver disease, diabetes, hypertension, obesity, dialysis or sever renal J o u r n a l P r e -p r o o f patients (on 17 th March 2021) [11] in each prefecture for model B.

The independent variable, the NEWS at the time of admission, was assumed to follow a Poisson distribution. We set four separate sampling chains, each consisting of 12,000 random samples, including 1,000 burnin. The sampling convergence was evaluated using the Gelman-Rubin statistics (R-hat below 1.1) and by visually inspecting a trace plot. All analyses were conducted using the R software version 4.0.5 [12] . 

The results revealed the existing regional heterogeneity in the severity of COVID-19 cases at the time of admission in Japan. Our results suggest that the health policy of each prefecture might have an impact on the severity of hospitalized COVID-19 cases on admission.

We should take various factors into consideration when we interpret our results.

The potential factors associated with the variation of the severity on admission could be viewed from two directions, namely, the local epidemiology of COVID-19 and the COVID-19 healthcare policy in each prefecture. From the former viewpoint, a regional surge in the number of COVID-19 patients or a rapid increase in the severity of disease due to new SARS-CoV-2 variants may contribute to the change in the severity on admission [6] . However, our analysis did not include patients with new SARS-CoV-2 variants as the study period was limited to before March 2021. While it is possible that COVID-19 cases due to new variants carry a greater risk of serious illness, there was a substantial regional heterogeneity in the severity of COVID-19 cases at the time of admission, as previous studies have demonstrated [13] . Presumably, variants are contributing factors to the severity of COVID-19 cases, but it should be noted that other factors also have a non-negligible influence on the severity of disease.

The latter point is relevant to policymakers (and healthcare providers) in the J o u r n a l P r e -p r o o f municipalities, mainly related to the on-site indication for hospitalization that is operated in each prefecture. The policy implemented to manage the waves of infection could be affected by the total medical capacity in the area. The number of beds secured for COVID-19 patients is one of the major resources [13] . The number of beds per population in each prefecture was included as one of the fixed effects in model B, and the random effect of each prefecture did not drastically change. Also, the number of physicians eligible for COVID-19 management may have an impact as this factor could create a bottleneck for patient acceptance [14] . However, it is difficult to precisely grasp the number of physicians who are engaging in COVID-19 patient management. This is because the specialty of the medical doctor is not a good proxy for the number of physicians engaging in COVID-19 management under such an emergency period [15] .

Our analysis had several limitations. First, we examined data solely from Japan; thus, it is not appropriate to generalize our results globally. Nevertheless, it is easy to imagine that, even in other countries, there would be differences in health policies among local authorities and that they might have an impact on the management of COVID-19 cases. Second, we could not include other confounding factors, such as human resources and variance of SARS-CoV-2; these aspects should be addressed in future studies.

In conclusion, our analysis revealed a possible association between prefecture and an increased/decreased risk of severe COVID-19 infection at the time of admission.

In addition, the number of beds secured for COVID-19 patients in each prefecture is not a single cause of such heterogeneity; therefore, other factors could be significant for the management of COVID-19 cases in Japan. Countermeasures against COVID-19 will be more appropriate if we take these insights into consideration.

We thank all the participating facilities for their care of COVID-19 patients, and cooperation on data entry to the registry.

The data that support the findings of this study are available upon request to the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

J o u r n a l P r e -p r o o f "Research for risk assessment and implementation of crisis management functions for emerging and re-emerging infectious diseases."

None declared. J o u r n a l P r e -p r o o f 

Clinical Characteristics of Coronavirus Disease 2019 in China

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19

Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN

The performance of the National Early Warning Score and National Early Warning Score 2 in hospitalised patients infected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Labour and Welfare. Investigation about treatment conditions and number of beds: COVID-19 n.d

R: A Language and Environment for Statistical Computing

Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries

Health systems resilience in managing the COVID-19 pandemic: lessons from 28 countries

Hospital capacity during the COVID-19 pandemic